Global Non-ionic Monomeric Contrast Medium 麻豆原创 Research Report 2024

Publication ID:

PB507242019

Publication Date:

July 18, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Non-ionic Monomeric Contrast Medium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Non-ionic Monomeric Contrast Medium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-ionic Monomeric Contrast Medium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-ionic Monomeric Contrast Medium include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, YRPG, BeiLu Pharma and Daiichi Sankyo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-ionic Monomeric Contrast Medium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-ionic Monomeric Contrast Medium.
Report Scope
The Non-ionic Monomeric Contrast Medium market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-ionic Monomeric Contrast Medium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-ionic Monomeric Contrast Medium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Daiichi Sankyo
Takeda
Grupo Juste
Fuji Pharma
Segment by Type
X-ray and CT Contrast Medium
MRI Contrast Medium
Ultrasound Contrast Medium
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-ionic Monomeric Contrast Medium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-ionic Monomeric Contrast Medium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Non-ionic Monomeric Contrast Medium 麻豆原创 Overview
1.1 Product Overview and Scope of Non-ionic Monomeric Contrast Medium
1.2 Non-ionic Monomeric Contrast Medium Segment by Type
1.2.1 Global Non-ionic Monomeric Contrast Medium 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 X-ray and CT Contrast Medium
1.2.3 MRI Contrast Medium
1.2.4 Ultrasound Contrast Medium
1.3 Non-ionic Monomeric Contrast Medium Segment by Application
1.3.1 Global Non-ionic Monomeric Contrast Medium 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Non-ionic Monomeric Contrast Medium 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Non-ionic Monomeric Contrast Medium Revenue 2019-2030
1.4.2 Global Non-ionic Monomeric Contrast Medium Sales 2019-2030
1.4.3 Global Non-ionic Monomeric Contrast Medium 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-ionic Monomeric Contrast Medium 麻豆原创 Competition by Manufacturers
2.1 Global Non-ionic Monomeric Contrast Medium Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Non-ionic Monomeric Contrast Medium Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Non-ionic Monomeric Contrast Medium Average Price by Manufacturers (2019-2024)
2.4 Global Non-ionic Monomeric Contrast Medium Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-ionic Monomeric Contrast Medium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-ionic Monomeric Contrast Medium, Product Type & Application
2.7 Non-ionic Monomeric Contrast Medium 麻豆原创 Competitive Situation and Trends
2.7.1 Non-ionic Monomeric Contrast Medium 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-ionic Monomeric Contrast Medium Players 麻豆原创 Share by Revenue
2.7.3 Global Non-ionic Monomeric Contrast Medium 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-ionic Monomeric Contrast Medium Retrospective 麻豆原创 Scenario by Region
3.1 Global Non-ionic Monomeric Contrast Medium 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-ionic Monomeric Contrast Medium Global Non-ionic Monomeric Contrast Medium Sales by Region: 2019-2030
3.2.1 Global Non-ionic Monomeric Contrast Medium Sales by Region: 2019-2024
3.2.2 Global Non-ionic Monomeric Contrast Medium Sales by Region: 2025-2030
3.3 Global Non-ionic Monomeric Contrast Medium Global Non-ionic Monomeric Contrast Medium Revenue by Region: 2019-2030
3.3.1 Global Non-ionic Monomeric Contrast Medium Revenue by Region: 2019-2024
3.3.2 Global Non-ionic Monomeric Contrast Medium Revenue by Region: 2025-2030
3.4 North America Non-ionic Monomeric Contrast Medium 麻豆原创 Facts & Figures by Country
3.4.1 North America Non-ionic Monomeric Contrast Medium 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-ionic Monomeric Contrast Medium Sales by Country (2019-2030)
3.4.3 North America Non-ionic Monomeric Contrast Medium Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-ionic Monomeric Contrast Medium 麻豆原创 Facts & Figures by Country
3.5.1 Europe Non-ionic Monomeric Contrast Medium 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-ionic Monomeric Contrast Medium Sales by Country (2019-2030)
3.5.3 Europe Non-ionic Monomeric Contrast Medium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-ionic Monomeric Contrast Medium 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Non-ionic Monomeric Contrast Medium 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-ionic Monomeric Contrast Medium Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-ionic Monomeric Contrast Medium Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-ionic Monomeric Contrast Medium 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Non-ionic Monomeric Contrast Medium 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-ionic Monomeric Contrast Medium Sales by Country (2019-2030)
3.7.3 Latin America Non-ionic Monomeric Contrast Medium Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-ionic Monomeric Contrast Medium 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Non-ionic Monomeric Contrast Medium 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-ionic Monomeric Contrast Medium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-ionic Monomeric Contrast Medium Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-ionic Monomeric Contrast Medium Sales by Type (2019-2030)
4.1.1 Global Non-ionic Monomeric Contrast Medium Sales by Type (2019-2024)
4.1.2 Global Non-ionic Monomeric Contrast Medium Sales by Type (2025-2030)
4.1.3 Global Non-ionic Monomeric Contrast Medium Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Non-ionic Monomeric Contrast Medium Revenue by Type (2019-2030)
4.2.1 Global Non-ionic Monomeric Contrast Medium Revenue by Type (2019-2024)
4.2.2 Global Non-ionic Monomeric Contrast Medium Revenue by Type (2025-2030)
4.2.3 Global Non-ionic Monomeric Contrast Medium Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Non-ionic Monomeric Contrast Medium Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-ionic Monomeric Contrast Medium Sales by Application (2019-2030)
5.1.1 Global Non-ionic Monomeric Contrast Medium Sales by Application (2019-2024)
5.1.2 Global Non-ionic Monomeric Contrast Medium Sales by Application (2025-2030)
5.1.3 Global Non-ionic Monomeric Contrast Medium Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Non-ionic Monomeric Contrast Medium Revenue by Application (2019-2030)
5.2.1 Global Non-ionic Monomeric Contrast Medium Revenue by Application (2019-2024)
5.2.2 Global Non-ionic Monomeric Contrast Medium Revenue by Application (2025-2030)
5.2.3 Global Non-ionic Monomeric Contrast Medium Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Non-ionic Monomeric Contrast Medium Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GE Healthcare Non-ionic Monomeric Contrast Medium Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Non-ionic Monomeric Contrast Medium Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bracco Imaging Non-ionic Monomeric Contrast Medium Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Guerbet Group
6.4.1 Guerbet Group Corporation Information
6.4.2 Guerbet Group Description and Business Overview
6.4.3 Guerbet Group Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guerbet Group Non-ionic Monomeric Contrast Medium Product Portfolio
6.4.5 Guerbet Group Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Corporation Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hengrui Medicine Non-ionic Monomeric Contrast Medium Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lantheus Non-ionic Monomeric Contrast Medium Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 YRPG
6.6.1 YRPG Corporation Information
6.6.2 YRPG Description and Business Overview
6.6.3 YRPG Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 YRPG Non-ionic Monomeric Contrast Medium Product Portfolio
6.7.5 YRPG Recent Developments/Updates
6.8 BeiLu Pharma
6.8.1 BeiLu Pharma Corporation Information
6.8.2 BeiLu Pharma Description and Business Overview
6.8.3 BeiLu Pharma Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BeiLu Pharma Non-ionic Monomeric Contrast Medium Product Portfolio
6.8.5 BeiLu Pharma Recent Developments/Updates
6.9 Daiichi Sankyo
6.9.1 Daiichi Sankyo Corporation Information
6.9.2 Daiichi Sankyo Description and Business Overview
6.9.3 Daiichi Sankyo Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Daiichi Sankyo Non-ionic Monomeric Contrast Medium Product Portfolio
6.9.5 Daiichi Sankyo Recent Developments/Updates
6.10 Takeda
6.10.1 Takeda Corporation Information
6.10.2 Takeda Description and Business Overview
6.10.3 Takeda Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Takeda Non-ionic Monomeric Contrast Medium Product Portfolio
6.10.5 Takeda Recent Developments/Updates
6.11 Grupo Juste
6.11.1 Grupo Juste Corporation Information
6.11.2 Grupo Juste Non-ionic Monomeric Contrast Medium Description and Business Overview
6.11.3 Grupo Juste Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Grupo Juste Non-ionic Monomeric Contrast Medium Product Portfolio
6.11.5 Grupo Juste Recent Developments/Updates
6.12 Fuji Pharma
6.12.1 Fuji Pharma Corporation Information
6.12.2 Fuji Pharma Non-ionic Monomeric Contrast Medium Description and Business Overview
6.12.3 Fuji Pharma Non-ionic Monomeric Contrast Medium Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Fuji Pharma Non-ionic Monomeric Contrast Medium Product Portfolio
6.12.5 Fuji Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-ionic Monomeric Contrast Medium Industry Chain Analysis
7.2 Non-ionic Monomeric Contrast Medium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-ionic Monomeric Contrast Medium Production Mode & Process
7.4 Non-ionic Monomeric Contrast Medium Sales and 麻豆原创ing
7.4.1 Non-ionic Monomeric Contrast Medium Sales Channels
7.4.2 Non-ionic Monomeric Contrast Medium Distributors
7.5 Non-ionic Monomeric Contrast Medium Customers
8 Non-ionic Monomeric Contrast Medium 麻豆原创 Dynamics
8.1 Non-ionic Monomeric Contrast Medium Industry Trends
8.2 Non-ionic Monomeric Contrast Medium 麻豆原创 Drivers
8.3 Non-ionic Monomeric Contrast Medium 麻豆原创 Challenges
8.4 Non-ionic Monomeric Contrast Medium 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Daiichi Sankyo
Takeda
Grupo Juste
Fuji Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.